药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Hydralazine
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Crizotinib.
Hydralazine
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Crizotinib.
Hydralazine
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Crizotinib.
Hydralazine
Anisodamine
The risk or severity of QTc prolongation can be increased when Anisodamine is combined with Crizotinib.
Hydralazine
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Crizotinib.
Hydralazine
Rupatadine
The risk or severity of QTc prolongation can be increased when Rupatadine is combined with Crizotinib.
Hydralazine
Bilastine
The risk or severity of QTc prolongation can be increased when Bilastine is combined with Crizotinib.
Hydralazine
Difloxacin
The risk or severity of QTc prolongation can be increased when Difloxacin is combined with Crizotinib.
Hydralazine
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Sarafloxacin is combined with Crizotinib.
Hydralazine
Phosmet
The risk or severity of QTc prolongation can be increased when Phosmet is combined with Crizotinib.
Hydralazine
Orbifloxacin
The risk or severity of QTc prolongation can be increased when Orbifloxacin is combined with Crizotinib.
Hydralazine
Fenthion
The risk or severity of QTc prolongation can be increased when Fenthion is combined with Crizotinib.
Hydralazine
Famphur
The risk or severity of QTc prolongation can be increased when Famphur is combined with Crizotinib.
Hydralazine
Dichlorvos
The risk or severity of QTc prolongation can be increased when Dichlorvos is combined with Crizotinib.
Hydralazine
Coumaphos
The risk or severity of QTc prolongation can be increased when Coumaphos is combined with Crizotinib.
Hydralazine
Acrivastine
The risk or severity of QTc prolongation can be increased when Acrivastine is combined with Crizotinib.
Hydralazine
Lacidipine
The risk or severity of QTc prolongation can be increased when Lacidipine is combined with Crizotinib.
Hydralazine
Aranidipine
The risk or severity of QTc prolongation can be increased when Aranidipine is combined with Crizotinib.
Hydralazine
Pinaverium
The risk or severity of QTc prolongation can be increased when Pinaverium is combined with Crizotinib.
Hydralazine
Trimebutine
The risk or severity of QTc prolongation can be increased when Trimebutine is combined with Crizotinib.